Brief: Femasys Expands Fertility Care Portfolio In Europe With CE Mark Approval For Femhsg™ Catheter
13/05/2026 14:06
May 13 (Reuters) - Femasys Inc FEMY.O: FEMASYS EXPANDS FERTILITY CARE PORTFOLIO IN EUROPE WITH CE MARK APPROVAL FOR FEMHSG™ CATHETER Source text: ID:nGNX9Hd3H9 Further company coverage: FEMY.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Femasys
See all newsBrief: Femasys - Files For Resale Of Up To 28,124,997 Shares Of Common Stock - SEC Filing
Brief: Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc
Femasys Inc reports results for the quarter ended June 30 - Earnings Summary
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview